Analysis
PublicCELLPHIRE, INC holds $39.0M across 1 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 3 offers. Set-aside status: SBA. Recompete timing centers on the Oct 31, 2028 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
SBARecompete timing
PublicCurrent PoP ends Oct 31, 2028 (806 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around May 1, 2027.
Watch this contract — one email →Incumbent footprint
Public recordCELLPHIRE, INC — $39.0M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open CELLPHIRE, INC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract W81XWH20C0030?
W81XWH20C0030 (PHASE II CLINICAL TRIAL) is a Department of Defense (DOD) award with an estimated value of $70.3M, currently held by CELLPHIRE, INC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on W81XWH20C0030?
CELLPHIRE, INC is the incumbent with $39.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2028.
When does W81XWH20C0030 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →